Morpholine → [2-(2-Morpholin-4-yl-ethoxy)-5-oxo-tetrahydro-furan-3-yl]-carbamic acid allyl ester
Reaction equation
[CH2:1]([O:4][C:5](=[O:17])[NH:6][CH:7]1[CH2:11][C:10](=[O:12])[O:9][CH:8]1[O:13][CH2:14][CH2:15]Cl)[CH:2]=[CH2:3].[NH:18]1[CH2:23][CH2:22][O:21][CH2:20][CH2:19]1>CN(C=O)C>[CH2:1]([O:4][C:5](=[O:17])[NH:6][CH:7]1[CH2:11][C:10](=[O:12])[O:9][CH:8]1[O:13][CH2:14][CH2:15][N:18]1[CH2:23][CH2:22][O:21][CH2:20][CH2:19]1)[CH:2]=[CH2:3]Participants
4
Procedure
Is prepared from [2-(2-chloro-ethoxy)-5-oxo-tetrahydro-furan-3-yl]-carbamic acid allyl ester by reaction with morpholine (2 eq) and KI (1 eq) in DMF.
Sources & evidence
- ORD record
- ord-94c8d908a17c458781f3b21448e6782e
- Source dataset
- uspto-grants-2014_04
- Patent number
- US08691848B2
Reaction notes
Loading…